Results 31 to 40 of about 1,999,691 (336)

Study protocol: addressing evidence and context to facilitate transfer and uptake of consultation recording use in oncology: a knowledge translation implementation study [PDF]

open access: yes, 2011
Background: The time period from diagnosis to the end of treatment is challenging for newly diagnosed cancer patients. Patients have a substantial need for information, decision aids, and psychosocial support.
Degner, Lesley F   +4 more
core   +2 more sources

Precision oncology: the intention-to-treat analysis fallacy. [PDF]

open access: yes, 2020
It has recently been suggested that precision oncology studies should be reanalysed using the intention-to-treat (ITT) methodology developed for randomized controlled clinical trials.
Kato, Shumei   +3 more
core   +1 more source

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications [PDF]

open access: yes, 2019
© 2019 Salek, Lussier Hoskyn, Johns, Allen and Sehgal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).This analysis follows our recent study showing that Canadian public reimbursement delays
Adcock   +15 more
core   +3 more sources

Pharmacovigilance in oncology [PDF]

open access: yesInternational Journal of Clinical Pharmacy, 2018
AbstractBackground Side effects of cancer therapy are one of the most important issues faced by cancer patients during their illness. Pharmacovigilance, namely the science and activities aimed at monitoring the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of antineoplastic agents, their narrow ...
Paolo Baldo   +4 more
openaire   +3 more sources

Attitudes of advanced Australian medical oncology trainees to rural practice [PDF]

open access: yes, 2008
Aim: To identify the views of medical oncology trainees regarding rural training posts and rural practice overall, and to identify factors that may improve recruitment. Methods: A questionnaire was posted to all advanced oncology trainees in Australia
Clarke, Kerrie A.   +4 more
core   +1 more source

Polypharmacy and potentially inappropriate medication use in geriatric oncology. [PDF]

open access: yes, 2016
Polypharmacy is a highly prevalent problem in older persons, and is challenging to assess and improve due to variations in definitions of the problem and the heterogeneous methods of medication review and reduction.
Aparicio   +65 more
core   +2 more sources

Predicting opioid therapy safety in pancreatic cancer patients

open access: yesRussian Open Medical Journal, 2020
Background — Obligatory use of strong opioids for treating chronic pain syndrome in patients with pancreatic cancer provides the implementation of opioid-associated adverse reactions.
Olga P. Bobrova   +3 more
doaj   +1 more source

Adjuvant therapy for early uterine high-grade leiomyosarcoma [PDF]

open access: yes, 2019
TO THE EDITOR: The article by Hensley et al1 recently published in Journal of Clinical Oncology was interesting, even if apparently negative (Gynecology Oncology Group [GOG]-0277 randomized phase III trial). The study investigated the activity and safety
Panici, P. B., Tomao, F., Tomao, S.
core   +1 more source

Magnons in Ferromagnetic Metallic Manganites [PDF]

open access: yes, 2007
Ferromagnetic (FM) manganites, a group of likely half-metallic oxides, are of special interest not only because they are a testing ground of the classical doubleexchange interaction mechanism for the colossal magnetoresistance, but also because they ...
Dai, Pengcheng   +5 more
core   +1 more source

Fibrolamellar Carcinoma: A Multimodal Approach

open access: yesGE: Portuguese Journal of Gastroenterology, 2020
Fibrolamellar carcinoma is a rare variant of hepatocellular carcinoma not associated with cirrhosis or viral hepatitis. Serum alpha-fetoprotein levels are usually normal; the histology is of a well-differentiated tumor, and the staging is the same as for
João Vasco Barreira   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy